|
Match
|
Document |
Document Title |
|
|
6630162 |
Pharmaceutical formulation and its use
The invention relates to a pharmaceutical formulation containing tolterodine or a tolterodine-related compound, or a pharmacologically acceptable salt thereof, as active ingredient, in which the...
|
|
|
6627223 |
Timed pulsatile drug delivery systems
A pharmaceutical dosage form such as a capsule capable of delivering therapeutic agents into the body in a time-controlled or position-controlled pulsatile release fashion, is composed of a...
|
|
|
6627222 |
Amoxicillin-dicloxacillin antibiotic composition
An antibiotic product for delivering at least Amoxicillin or dicloxacillin that is comprised of three dosage forms with different release profiles with each of Amoxicillin and dicloxacillin being...
|
|
|
6623756 |
Directly compressed solid dosage articles
Solid dosage articles such as pharmaceutical tablets for the controlled release of a desired compound such as an active ingredient are directly compressed from a flowable, compressible mixture of...
|
|
|
6620432 |
Phenytoin sodium pharmaceutical compositions
A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The...
|
|
|
6610323 |
Oral pharmaceutical pulsed release dosage form
An enteric coated pharmaceutical dosage form comprising an H + ,K + -ATPase inhibitor is disclosed. The dosage form comprises at least two portions of the H + ,K + - ATPase inhibitor to be released...
|
|
|
6610328 |
Amoxicillin-clarithromycin antibiotic composition
An antibiotic product for delivering at least Amoxicillin or Clarithromycin that is comprised of three dosage forms with different release profiles with each of Amoxicillin and Clarithromycin being...
|
|
|
6605300 |
Oral pulsed dose drug delivery system
A multiple pulsed dose drug delivery system for pharmaceutically active amphetamine salts, comprising an immediate-release component and an enteric delayed-release component wherein (1) the enteric...
|
|
|
6605303 |
Oral pharmaceutical extended release dosage form
An enteric coated pharmaceutical extended release dosage form of a H + , K + -ATPase inhibitor giving an extended plasma concentration profile of a H + , K + -ATPase inhibitor. The extended plasma...
|
|
|
6599529 |
Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs)
An oral pharmaceutical modified release multiple-units composition for the administration of a therapeutically and/or prophylactically effective amount of a non-steroid anti-inflammatory drug...
|
|
|
6599931 |
Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone
A test system for characterizing the compatibility of bioactive substances with polyvinylpyrrolidones in a solid dispersion consisting of one or more bioactive substances and...
|
|
|
6596311 |
Fast disintegrating tablets
This invention provides a formulation for preparing a fast disintegrating tablet comprising a drug in multiparticulate form, one or more water insoluble inorganic excipients, one or more...
|
|
|
6592897 |
Slow release tablet prepared from linear water-insoluble polysacchrides
The invention relates to a controlled release tablet which in part or as a whole contains water-insoluble linear polysaccharides, preferably the polysaccharide poly(1,4-α-D-glucan), in the form of...
|
|
|
6592902 |
Controlled release eplerenone compositions
The invention relates to oral pharmaceutical compositions useful as aldosterone receptor blockers comprising the active agent micronized eplerenone in an amount of about 10 mg to about 1000 mg and...
|
|
|
6576260 |
Sustained-release form of administration containing tramadol saccharinate
Disclosed herein is sustained-release formulations of tramadol comprising tramadol saccharinate coated with at least one sustained-release coating. The sustained release formulations may also...
|
|
|
6572889 |
Controlled release solid dosage carbamazepine formulations
A polymer or copolymer composition derived from one or more unsaturated carboxylic acids that is cross-linked and carbamazepine in conjunction with conventional materials such as fillers,...
|
|
|
6569455 |
Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates
The present invention relates to stable quick-release extrudates that contain low-viscosity hydroxypropylcellulose and at least one active ingredient. This invention also relates to a method for...
|
|
|
6565883 |
Controlled release oral compositions comprising rivastigmine
Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigamine, in a time-controlled manner.
|
|
|
6558703 |
Porous hydroxyapatite particles as carriers for drug substances
A drug delivery system for oral administration in solid dry form of a greasy/oily/sticky substance and a pharmaceutically active substance or a pharmaceutically active substance which itself is...
|
|
|
6558699 |
High drug load immediate and modified release oral dosage formulations and processes for their manufacture
This invention relates to high drug load granulation of (E)-α-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-
yl]methylene-2-thiophenepropionic acid in the anhydrous form, a process for its...
|
|
|
6558701 |
Multilayer tablet for administering a fixed combination of tramadol and diclofenac
A multilayer tablet for oral administration containing at least one Tramadol layer including Tramadol or a physiologically acceptable salt thereof; at least one diclofenac layer including...
|
|
|
6558700 |
Multiple-unit sustained release tablets
A multiple-unit sustained release tablet characterized by consisiting of a granular part and a powdery part, each granule comprising a matrix composed of a water-insoluble polymer and an active...
|
|
|
6555136 |
Pharmaceutical dosage form for pulsatile delivery of methylphenidate
Novel pharmaceutical dosage forms provide for pulsatile delivery of methylphenidate, i.e., release encapsulated drug in spaced apart “pulses.” The dosage forms are comprised of first, second...
|
|
|
6555137 |
Sucralfate-containing composition and process for the preparation thereof
A coated antacid comprising sucralfate and an antacid inhibits decline in the adhesion characteristics of sucralfate whereby the drug ingested can reliably show its effect in the stomach. This...
|
|
|
6551618 |
Compositions and methods for delivery of agents for neuronal regeneration and survival
Devices useful in the delivery of DNA encoding neurotrophic agents, anti-fibrotic agents, and related compositions are disclosed herein for use in the treatment of central and/or peripheral nervous...
|
|
|
6548083 |
Prolonged release active agent dosage form adapted for gastric retention
The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid...
|
|
|
6544556 |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
An oral solid dosage form includes a therapeutically effective amount of an NSAID and a proton pump inhibitor in an amount effective to inhibit or prevent gastrointestinal side effects normally...
|
|
|
6544553 |
Dosage forms and methods for oral delivery of progesterone
Provided is an oral dosage form suitable to deliver a combined dosage of progesterone and which upon delivery through the gastrointestinal tract provides a blood concentration of from about 0.1...
|
|
|
6534089 |
Uniform drug delivery therapy
The invention disclosed pertains to a novel delivery system comprising an agent formulation and means for dispensing the agent formulation from the delivery system.
|
|
|
6534088 |
Fibrate-statin combinations with reduced fed-fasted effects
This invention discloses an orally administered pharmaceutical composition for the treatment of elevated levels of cholesterol and related conditions comprising a statin and fenofibrate in the form...
|
|
|
6534090 |
Oral osmotic controlled drug delivery system for a sparingly soluble drug
The present invention is for an oral osmotic controlled drug delivery system for a sparingly soluble drug comprising: a. a core comprising (i) finely particulate anhydrous carbamazepine (ii) a...
|
|
|
6531158 |
Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
The present invention provides a drug delivery system for the oral administration of a hydrophobic active ingredient. The active ingredient's post-ingestion dissolution rate and its corresponding...
|
|
|
6524618 |
Directly compressible extended-release matrix formulation for metformin hydrochloride
An extended-release matrx formulation capable of being directly compressed into tablets comprising metformin hydrochloride blended with specific excipients. The excipients used in the formulation...
|
|
|
6517866 |
Sertraline salts and sustained-release dosage forms of sertraline
Sustained release dosage forms of sertraline which release sertraline at a rate between 1 mgA/hr and 40 mgA/hr. The dosage forms may exhibit an initial delay period during which sertraline is...
|
|
|
6514531 |
Controlled-release dosage forms comprising zolpidem or a salt thereof
The present invention relates to controlled-release dosage forms of zolpidem or salts thereof adapted to release zolpidem over a predetermined time period, according to a biphasic profile of...
|
|
|
6488962 |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
The retention of oral drug dosage forms in the stomach is improved by using swellable dosage forms that are shaped in a manner that will prevent them from inadvertently passing through the pylorus...
|
|
|
6485743 |
Method and composition of an oral preparation of itraconazole
The present invention relates to a method and composition of an oral preparation of itraconazole, an excellent azole antifungal drug. More particularly, it relates to an oral preparation of...
|
|
|
6485759 |
Botanical combinations for treating AIDS and immune-deficient patients to maintain good health and the process for preparing the same
Botanical Combination therapies for treating AIDS and immune-deficient patients include therapeutically effective doses of five medicinal plants of Thailand. First combination, ayurvedic...
|
|
|
6482434 |
Method for reducing adverse effects of a weight loss regimen
A method for reducing certain effects associated with a negative calorie balance in a human includes the step of administering conjugated linoleic acid to a human in an amount effective to reduce...
|
|
|
6475521 |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method
A biphasic controlled release delivery system for pharmaceuticals which have high water solubility, such as the antidiabetic metformin HCl salt, is provided which provides a dosage form that has...
|
|
|
6468976 |
Monohydrate lisinopril
The present invention relates to a novel monohydrate form of 1-(N 2 -[(S)-1-carboxy-3-phenylpropyl]-L-lysyl)-L-proline known under the generic name lisinopril. Further, the present invention also...
|
|
|
6468959 |
Peroral dosage form for peptide containing medicaments, in particular insulin
There is provided a plural dosage form for peptide pharmaceuticals comprising a matrix of gelatin or gelatin derivative having distributed therein the peptide pharmaceutical in particular insulin,...
|
|
|
6462022 |
Lisinopril compositions having large-particle DCPD
The present invention relates to a pharmaceutical composition comprising lisinopril and dibasic calcium phosphate dihydrate (DCPD), produced by a process comprising mixing lisinopril and DCPD with...
|
|
|
6451345 |
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
The present invention provides taste-masked microcapsules of Linezolid or the like (any member of the orally effective oxazolidinone or macrolide antibiotics), suitable for oral administration as a...
|
|
|
6399096 |
Pharmaceutical formulation
A solid, oral controlled release pharmaceutical dosage form has a water-soluble active ingredient dispersed in a matrix and releases the active ingredient at such a rate upon administration that...
|
|
|
6399100 |
Controlled release pharmaceutical compositions containing tiagabine
Controlled release oral pharmaceutical preparations are provided which comprise a therapeutically effective amount of tiagabine or a pharmaceutically acceptable salt thereof dispersed in a rate...
|
|
|
6391338 |
System for rendering substantially non-dissoluble bio-affecting agents bio-available
The present invention is a method of preparing a system for delivering a bio-affecting agent and the composition prepared thereby. The invention includes forming a molecular dispersion of the...
|
|
|
6372255 |
Tablet for instant and prolonged release of one or more active substances
A multi-layer tablet for the instant and prolonged release of active substances comprises at least two layers where the first outer layer comprises a mixture of excipients and an active substance,...
|
|
|
6365185 |
Self-destructing, controlled release peroral drug delivery system
The present invention relates to tablets which are time-controlled to release active agent at different rates in different regions of the digestive tract in order to maintain a substantially...
|
|
|
6365180 |
Oral liquid compositions
The present invention relates to novel, liquid and semi-solid pharmaceutical compositions which can be administered in liquid form or can be used for preparing capsules containing such...
|